In contrast to earlier conferences in 2025, experts interviewed as part of the BIO conference in Boston did not come to a consensus about lasting impacts of recent changes in US government policy.
BIO International Convention
The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.
Advertisement
The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI Frankfurt in October 2025.
PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, ahead of BIO 2025 to find out what’s new in pulmonary drug delivery.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Audits, Inspections, and CDMOs
2
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
3
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
4
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
5
